IONS — IONIS PHARMACEUTICALS INC

Ownership history in Edgestream Partners, L.P.  ·  4 quarters on record

This page tracks every 13F SEC filing in which Edgestream Partners, L.P. reported a position in IONIS PHARMACEUTICALS INC (IONS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.12% (2022 Q4)
Avg. % of fund
0.06%
First filed
2021 Q2
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 5,450 -12,196 -69.1% 0.01% $357K $65.42
2024 Q1 REDUCED 17,646 -9,747 -35.6% 0.04% $765K $43.35
2022 Q4 REDUCED 27,393 -3,869 -12.4% 0.12% $1.0M $37.77
2021 Q2 INITIATED 31,262 — — 0.07% $1.2M $39.89
% of Fund (quarterly)    IONS price (monthly, adj. close)

Other funds also holding IONS

As of 2025 Q4 — sorted by position size

Tweedy, Browne Co LLC 3Y 7Y 15.74% BOONE CAPITAL MANAGEMENT LLC 3Y 10.37% Bellevue Group AG 3Y 7Y 7.2% Tri Locum Partners LP 3Y 5.72% Orion Investment Co 5.43% Exome Asset Management LLC 4.41% Privium Fund Management B.V. 3Y 3.51% Sicart Associates LLC 3Y 7Y 3.43% SECTOR GAMMA AS 3Y 7Y 3.34% SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3Y 7Y 2.41%
← Back to Edgestream Partners, L.P. Holdings